dc.contributor.author | Sergijenko, Ana | |
dc.contributor.author | Langford-Smith, Alexander | |
dc.contributor.author | Liao, Ai Y | |
dc.contributor.author | Pickford, Claire E | |
dc.contributor.author | McDermott, John | |
dc.contributor.author | Nowinski, Gabriel | |
dc.contributor.author | Langford-Smith, Kia J | |
dc.contributor.author | Merry, Catherine L R | |
dc.contributor.author | Jones, Simon A | |
dc.contributor.author | Wraith, J Edmond | |
dc.contributor.author | Wynn, Robert F | |
dc.contributor.author | Wilkinson, Fiona L | |
dc.contributor.author | Bigger, Brian W | |
dc.date.accessioned | 2014-11-25T18:37:44Z | |
dc.date.available | 2014-11-25T18:37:44Z | |
dc.date.issued | 2013-10 | |
dc.identifier.citation | Sergijenko , A , Langford-Smith , A , Liao , A Y , Pickford , C E , McDermott , J , Nowinski , G , Langford-Smith , K J , Merry , C L R , Jones , S A , Wraith , J E , Wynn , R F , Wilkinson , F L & Bigger , B W 2013 , ' Myeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease ' , Molecular therapy : the journal of the American Society of Gene Therapy , vol. 21 , no. 10 , pp. 1938-49 . https://doi.org/10.1038/mt.2013.141 | en |
dc.identifier.issn | 1525-0024 | |
dc.identifier.other | PURE: 44341132 | |
dc.identifier.other | PURE UUID: 291d7692-990b-4de6-8711-f0a15e934592 | |
dc.identifier.other | PubMed: 23748415 | |
dc.identifier.other | Scopus: 84885018977 | |
dc.identifier.uri | http://hdl.handle.net/2164/4001 | |
dc.format.extent | 12 | |
dc.language.iso | eng | |
dc.relation.ispartof | Molecular therapy : the journal of the American Society of Gene Therapy | en |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/. | en |
dc.subject | Animals | en |
dc.subject | Antigens, CD11b | en |
dc.subject | Brain | en |
dc.subject | Cell Line | en |
dc.subject | Disease Models, Animal | en |
dc.subject | Female | en |
dc.subject | Genetic Therapy | en |
dc.subject | Genetic Vectors | en |
dc.subject | Green Fluorescent Proteins | en |
dc.subject | Hematopoietic Stem Cell Transplantation | en |
dc.subject | Hematopoietic Stem Cells | en |
dc.subject | Heparitin Sulfate | en |
dc.subject | Humans | en |
dc.subject | Hydrolases | en |
dc.subject | Lentivirus | en |
dc.subject | Leukocytes | en |
dc.subject | Lysosomes | en |
dc.subject | Mice | en |
dc.subject | Mice, Inbred C57BL | en |
dc.subject | Microglia | en |
dc.subject | Mucopolysaccharidosis III | en |
dc.subject | Myeloid Cells | en |
dc.subject | Organ Specificity | en |
dc.subject | Promoter Regions, Genetic | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Myeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1038/mt.2013.141 | |